On 19 June 2018 the Senate referred the following matter to the Foreign Affairs, Defence and Trade References Committee for inquiry and report by 17 September 2018:
The use of the Quinoline anti-malarial drugs Mefloquine and Tafenoquine in the Australian Defence Force.
Submissions to this inquiry close on 31 July 2018.
On 20 August 2018 the Senate agreed to extend the reporting date to 29 November 2018.
On 29 November 2018 the Senate agreed to extend the reporting date to 6 December 2018.